Cost--effectiveness of pap smear in Kermanshah, Iran.

Simple item page
dc.contributor.authorNokiani, Fariba Almassien_US
dc.contributor.authorAkbari, Hosseinen_US
dc.contributor.authorRezaei, Mansouren_US
dc.contributor.authorMadani, Hamiden_US
dc.contributor.authorAle Agha, Mohsen Emamien_US
dc.date.accessioned2009-05-27T17:39:13Z
dc.date.available2009-05-27T17:39:13Z
dc.date.issued2008-01-29en_US
dc.descriptionAsian Pacific Journal of Cancer Prevention.en_US
dc.description.abstractOBJECTIVE: To determine the incidence of pre invasive and invasive cervical lesions and also cost- effectiveness of Pap smears in Kermanshah, Iran (2004-2007). METHODS: A descriptive, cross sectional study was performed between March 2004-March 2007 with all cytological smears analyzed according to the Bethesda II system. Efficacy was estimated as the ratio of HSIL and invasive carcinomas detected to all Pap smears. Data were analyzed with SPSS software and mean+/-SD for cost in each age. RESULTS: 148,472 smears were analyzed of which 99.7 % were negative, only 0.3% having cytological abnormalities. ASCUS, LSIL, HSIL and carcinoma positive rates were 205.4, 73.4, 21.6 and 5.4 per 100,000 Pap smears respectively. The incidence of HSIL and carcinoma in total was 26.9 per 100,000 women. Before age 35 there were no such lesions so that the effectiveness of Pap smear before age 35 was zero. The cost for one smear was 5 Euros and the cost for detection per HSIL or carcinoma was 18,559 Euros. The mean age of women for HSIL was 52.0+/-10.7 and for carcinoma 48.1+/-1.81 years. CONCLUSIONS: Since no HSIL or carcinomas were detected before age 35, and since for changing one LSIL to HSIL or carcinoma should take more than 5 years , the results of this study suggest that Pap smears before 35 years old is not effective and we suggest commencement of Pap smear in Iran from age 30.en_US
dc.description.affiliationKermanshah University of Medical Sciences, Iran.en_US
dc.identifier.citationNokiani FA, Akbari H, Rezaei M, Madani H, Ale Agha ME. Cost--effectiveness of pap smear in Kermanshah, Iran. Asian Pacific Journal of Cancer Prevention. 2008 Jan-Mar; 9(1): 107-10en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/37603
dc.language.isoengen_US
dc.source.urihttps://www.apocp.orgen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshCarcinoma, Squamous Cell --diagnosisen_US
dc.subject.meshCervical Intraepithelial Neoplasia --diagnosisen_US
dc.subject.meshCervix Uteri --pathologyen_US
dc.subject.meshCost-Benefit Analysisen_US
dc.subject.meshCross-Sectional Studiesen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshIran --epidemiologyen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshNeoplasm Invasivenessen_US
dc.subject.meshUterine Cervical Neoplasms --diagnosisen_US
dc.subject.meshVaginal Smears --economicsen_US
dc.subject.meshYoung Adulten_US
dc.titleCost--effectiveness of pap smear in Kermanshah, Iran.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Asian Pacific Journal of Cancer Prevention